A natural antimicrobial formulation leveraging essential oils and surfactants as multifunctional preservatives for all-purpose cleaners. This solution addresses growing concerns over skin irritation from conventional chemical preservatives and rising bacterial resistance, offering a dual-function approach that combines cleaning efficacy with safe, naturally-derived preservation.
This research proposes the development of essential oil-based formulations that serve as natural, multifunctional preservatives in all-purpose cleaners (APC). The approach addresses two critical industry challenges: the skin irritation associated with conventional synthetic preservatives such as isothiazolinones, and the growing problem of bacterial resistance to standard antimicrobial agents. By harnessing the inherent antibacterial properties of essential oils, the formulation offers both antimicrobial action and product preservation in a single, naturally-derived system. The technology targets cleaning product manufacturers seeking safer, more sustainable preservative alternatives without compromising efficacy.
Core approach:
Key essential oil candidates under investigation:
The research is in the early-to-mid stage of formulation development, with planned activities including antimicrobial screening of essential oil candidates, optimization of antibacterial activity across different formulations, and determination of bacterial growth inhibition under varying conditions using multiple modeling approaches. Future validation will also include irritant potential assessment and proposal of the antibacterial mechanism. The project builds on established literature validating synergistic activities of essential oils with cosmetic preservatives and demonstrated antibacterial properties of specific oils. The technology is currently at the laboratory validation phase, with further formulation optimization and mechanistic studies required before commercial readiness.
SIBCo Medical and Pharmaceuticals Sdn. Bhd. is a Malaysia-incorporated division of the broader SIBCo Group, a conglomerate focused on Islamic economy and investment activities. The medical division is led by professionals with extensive experience in government, private, and NGO healthcare sectors. It is dedicated to participating in the medical and pharmaceutical industries as part of the group's wider efforts to structure investments and foster collaborative ventures across various sectors, including energy, infrastructure, and agriculture.
By leveraging the expertise of its leadership team, the company operates within a framework that emphasizes Shariah compliance and sustainable economic development. The medical unit serves as a critical component of the group's interest in sectors aligned with growing global demand, including nutraceuticals and general healthcare. Through this divisional approach, the company engages in planning and development activities intended to build trust with partners and counterparts while contributing to the group's diversified international business interests.